Treatments for Gastrointestinal Disorders
    2.
    发明申请
    Treatments for Gastrointestinal Disorders 有权
    胃肠道疾病治疗

    公开(公告)号:US20150094272A1

    公开(公告)日:2015-04-02

    申请号:US14239178

    申请日:2012-08-17

    摘要: The present invention features peptides, compositions, and related methods for treating gastrointestinal disorders and conditions, including but not limited to, irritable bowel syndrome (IBS), gastrointestinal motility disorders, functional gastrointestinal disorders, gastroesophageal reflux disease (GERD), duodenogastric reflux, Crohn's disease, ulcerative colitis, inflammatory bowel disease, functional heartburn, dyspepsia, visceral pain, gastroparesis, chronic intestinal pseudo-obstruction (or colonic pseudo-obstruction), disorders and conditions associated with constipation, and other conditions and disorders are described herein, using peptides and other agents that activate the guanylate cyclase C (GC-C) receptor.

    摘要翻译: 本发明涉及用于治疗胃肠道疾病和病症的肽,组合物和相关方法,包括但不限于肠易激综合征(IBS),胃肠蠕动障碍,功能性胃肠道疾病,胃食管反流病(GERD),十二指肠胃反流,克罗恩氏病 疾病,溃疡性结肠炎,炎性肠病,功能性胃灼热,消化不良,内脏痛,胃轻瘫,慢性肠假性梗阻(或结肠假性梗阻),与便秘相关的病症和病症以及其它病症和病症在本文中用肽描述 和激活鸟苷酸环化酶C(GC-C)受体的其它试剂。

    Treatments for gastrointestinal disorders
    3.
    发明授权
    Treatments for gastrointestinal disorders 有权
    胃肠道疾病治疗

    公开(公告)号:US08933030B2

    公开(公告)日:2015-01-13

    申请号:US13579685

    申请日:2011-02-17

    摘要: The present invention features peptides, compositions, and related methods for treating gastrointestinal disorders and conditions, including but not limited to, irritable bowel syndrome (IBS), gastrointestinal motility disorders, functional gastrointestinal disorders, gastroesophageal reflux disease (GERD), duodenogastric reflux, Crohn's disease, ulcerative colitis, inflammatory bowel disease, functional heartburn, dyspepsia, visceral pain, gastroparesis, chronic intestinal pseudo-obstruction (or colonic pseudo-obstruction), disorders and conditions associated with constipation, and other conditions and disorders are described herein, using peptides and other agents that activate the guanylate cyclase C (GC-C) receptor.

    摘要翻译: 本发明涉及用于治疗胃肠道疾病和病症的肽,组合物和相关方法,包括但不限于肠易激综合征(IBS),胃肠蠕动障碍,功能性胃肠道疾病,胃食管反流病(GERD),十二指肠胃反流,克罗恩氏病 疾病,溃疡性结肠炎,炎性肠病,功能性胃灼热,消化不良,内脏痛,胃轻瘫,慢性肠假性梗阻(或结肠假性梗阻),与便秘相关的病症和病症以及其它病症和病症在本文中用肽描述 和激活鸟苷酸环化酶C(GC-C)受体的其它试剂。

    Treatments for Gastrointestinal Disorders
    4.
    发明申请
    Treatments for Gastrointestinal Disorders 有权
    胃肠道疾病治疗

    公开(公告)号:US20140073571A9

    公开(公告)日:2014-03-13

    申请号:US13579685

    申请日:2011-02-17

    IPC分类号: C07K7/08 A61K45/06 A61K38/10

    摘要: The present invention features peptides, compositions, and related methods for treating gastrointestinal disorders and conditions, including but not limited to, irritable bowel syndrome (IBS), gastrointestinal motility disorders, functional gastrointestinal disorders, gastroesophageal reflux disease (GERD), duodenogastric reflux, Crohn's disease, ulcerative colitis, inflammatory bowel disease, functional heartburn, dyspepsia, visceral pain, gastroparesis, chronic intestinal pseudo-obstruction (or colonic pseudo-obstruction), disorders and conditions associated with constipation, and other conditions and disorders are described herein, using peptides and other agents that activate the guanylate cyclase C (GC-C) receptor.

    摘要翻译: 本发明涉及用于治疗胃肠道疾病和病症的肽,组合物和相关方法,包括但不限于肠易激综合征(IBS),胃肠蠕动障碍,功能性胃肠道疾病,胃食管反流病(GERD),十二指肠胃反流,克罗恩氏病 疾病,溃疡性结肠炎,炎性肠病,功能性胃灼热,消化不良,内脏痛,胃轻瘫,慢性肠假性梗阻(或结肠假性梗阻),与便秘相关的病症和病症以及其它病症和病症在本文中用肽描述 和激活鸟苷酸环化酶C(GC-C)受体的其它试剂。

    Treatments for Gastrointestinal Disorders

    公开(公告)号:US20130190238A1

    公开(公告)日:2013-07-25

    申请号:US13579685

    申请日:2011-02-17

    IPC分类号: C07K7/08 A61K45/06 A61K38/10

    摘要: The present invention features peptides, compositions, and related methods for treating gastrointestinal disorders and conditions, including but not limited to, irritable bowel syndrome (IBS), gastrointestinal motility disorders, functional gastrointestinal disorders, gastroesophageal reflux disease (GERD), duodenogastric reflux, Crohn's disease, ulcerative colitis, inflammatory bowel disease, functional heartburn, dyspepsia, visceral pain, gastroparesis, chronic intestinal pseudo-obstruction (or colonic pseudo-obstruction), disorders and conditions associated with constipation, and other conditions and disorders are described herein, using peptides and other agents that activate the guanylate cyclase C (GC-C) receptor.